STOCK TITAN

Profusa (PFSA) details new director and executive appointments in 8-K filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Profusa, Inc. filed a current report describing a corporate governance update. On August 19, 2025, the company issued a press release announcing the appointment of certain directors and executive officers. The press release is included as Exhibit 99.1, and the report is signed by Chief Executive Officer Ben Hwang.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
false 0001859807 0001859807 2025-08-19 2025-08-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 19, 2025

 

PROFUSA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41177   86-3437271
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

626 Bancroft Way, Suite A

Berkeley, CA 94710

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (925) 997-6925

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   PFSA   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 Item 8.01 Other Events.

 

On August 19, 2025, Profusa, Inc. (the “Company”) issued a press release regarding the appointment of certain directors and executive officers of the Company. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press Release, dated as of August 19, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 19, 2025 Profusa, Inc.
     
  By: /s/ Ben Hwang
  Name:  Ben Hwang
  Title: Chief Executive Officer

 

 

2

 

FAQ

What did Profusa (PFSA) report in this 8-K filing?

Profusa reported that on August 19, 2025 it issued a press release announcing the appointment of certain directors and executive officers.

Which item of Form 8-K did Profusa (PFSA) use for this disclosure?

The disclosure is made under Item 8.01 – Other Events, indicating an informational update rather than a mandated event under another specific item.

Does the Profusa (PFSA) 8-K include the full press release?

Yes. The press release about the appointment of directors and executive officers is furnished as Exhibit 99.1 to the report.

Who signed the August 19, 2025 Profusa (PFSA) 8-K?

The report was signed on behalf of Profusa, Inc. by Ben Hwang, the company’s Chief Executive Officer.

What securities of Profusa (PFSA) are listed on an exchange?

Profusa’s common stock, par value $0.0001 per share, trades on The Nasdaq Stock Market LLC under the symbol PFSA.

Are there financial statements included in this Profusa (PFSA) 8-K?

Under Item 9.01, the company lists only exhibits, including the press release and the cover page interactive data file; no financial statements are provided in this report.
Profusa Inc

NASDAQ:PFSA

View PFSA Stock Overview

PFSA Rankings

PFSA Latest News

PFSA Latest SEC Filings

PFSA Stock Data

645.16k
1.21M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK